Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

A disintegrin and metalloprotease 10 (ADAM10) is a central regulator of murine liver tissue homeostasis

M. Müller, S. Wetzel, J. Köhn-Gaone, K. Chalupsky, R. Lüllmann-Rauch, R. Barikbin, J. Bergmann, B. Wöhner, O. Zbodakova, I. Leuschner, G. Martin, G. Tiegs, S. Rose-John, R. Sedlacek, JE. Tirnitz-Parker, P. Saftig, D. Schmidt-Arras,

. 2016 ; 7 (14) : 17431-41.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc17014060

UNLABELLED: A Disintegrin And Metalloprotease (ADAM) 10 exerts essential roles during organ development and tissue integrity in different organs, mainly through activation of the Notch pathway. However, only little is known about its implication in liver tissue physiology. Here we show that in contrast to its role in other tissues, ADAM10 is dispensable for the Notch2-dependent biliary tree formation. However, we demonstrate that expression of bile acid transporters is dependent on ADAM10. Consequently, mice deficient for Adam10 in hepatocytes, cholangiocytes and liver progenitor cells develop spontaneous hepatocyte necrosis and concomitant liver fibrosis. We furthermore observed a strongly augmented ductular reaction in 15-week old ADAM10(Δhep/Δch) mice and demonstrate that c-Met dependent liver progenitor cell activation is enhanced. Additionally, liver progenitor cells are primed to hepatocyte differentiation in the absence of ADAM10. These findings show that ADAM10 is a novel central node controlling liver tissue homeostasis. HIGHLIGHTS: Loss of ADAM10 in murine liver results in hepatocyte necrosis and concomitant liver fibrosis. ADAM10 directly regulates expression of bile acid transporters but is dispensable for Notch2-dependent formation of the biliary system. Activation of liver progenitor cells is enhanced through increased c-Met signalling, in the absence of ADAM10. Differentiation of liver progenitor cells to hepatocytes is augmented in the absence of ADAM10.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014060
003      
CZ-PrNML
005      
20170427101956.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.18632/oncotarget.7836 $2 doi
035    __
$a (PubMed)26942887
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Müller, Miryam $u Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
245    12
$a A disintegrin and metalloprotease 10 (ADAM10) is a central regulator of murine liver tissue homeostasis / $c M. Müller, S. Wetzel, J. Köhn-Gaone, K. Chalupsky, R. Lüllmann-Rauch, R. Barikbin, J. Bergmann, B. Wöhner, O. Zbodakova, I. Leuschner, G. Martin, G. Tiegs, S. Rose-John, R. Sedlacek, JE. Tirnitz-Parker, P. Saftig, D. Schmidt-Arras,
520    9_
$a UNLABELLED: A Disintegrin And Metalloprotease (ADAM) 10 exerts essential roles during organ development and tissue integrity in different organs, mainly through activation of the Notch pathway. However, only little is known about its implication in liver tissue physiology. Here we show that in contrast to its role in other tissues, ADAM10 is dispensable for the Notch2-dependent biliary tree formation. However, we demonstrate that expression of bile acid transporters is dependent on ADAM10. Consequently, mice deficient for Adam10 in hepatocytes, cholangiocytes and liver progenitor cells develop spontaneous hepatocyte necrosis and concomitant liver fibrosis. We furthermore observed a strongly augmented ductular reaction in 15-week old ADAM10(Δhep/Δch) mice and demonstrate that c-Met dependent liver progenitor cell activation is enhanced. Additionally, liver progenitor cells are primed to hepatocyte differentiation in the absence of ADAM10. These findings show that ADAM10 is a novel central node controlling liver tissue homeostasis. HIGHLIGHTS: Loss of ADAM10 in murine liver results in hepatocyte necrosis and concomitant liver fibrosis. ADAM10 directly regulates expression of bile acid transporters but is dispensable for Notch2-dependent formation of the biliary system. Activation of liver progenitor cells is enhanced through increased c-Met signalling, in the absence of ADAM10. Differentiation of liver progenitor cells to hepatocytes is augmented in the absence of ADAM10.
650    _2
$a protein ADAM10 $x nedostatek $x genetika $x metabolismus $7 D000072197
650    _2
$a sekretasy $x nedostatek $x genetika $x metabolismus $7 D053829
650    _2
$a zvířata $7 D000818
650    _2
$a transportní proteiny $x metabolismus $7 D002352
650    _2
$a buněčná diferenciace $x fyziologie $7 D002454
650    _2
$a proliferace buněk $x fyziologie $7 D049109
650    _2
$a down regulace $7 D015536
650    _2
$a hepatocyty $x metabolismus $x patologie $7 D022781
650    _2
$a homeostáza $7 D006706
650    _2
$a játra $x cytologie $x metabolismus $x patologie $7 D008099
650    _2
$a membránové glykoproteiny $x metabolismus $7 D008562
650    _2
$a membránové proteiny $x nedostatek $x genetika $x metabolismus $7 D008565
650    _2
$a myši $7 D051379
650    _2
$a myši knockoutované $7 D018345
650    _2
$a myši transgenní $7 D008822
650    _2
$a nekróza $7 D009336
650    _2
$a receptor Notch2 $x metabolismus $7 D051883
650    _2
$a signální transdukce $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Wetzel, Sebastian $u Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
700    1_
$a Köhn-Gaone, Julia $u School of Biomedical Sciences, Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Bentley, Australia.
700    1_
$a Chalupsky, Karel $u Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the ASCR, Prague, Czech Republic.
700    1_
$a Lüllmann-Rauch, Renate $u Institute of Anatomy, Christian-Albrechts-University, Kiel, Germany.
700    1_
$a Barikbin, Roja $u Institute of Experimental Immunology and Hepatology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
700    1_
$a Bergmann, Juri $u Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany. Department of General and Thoracic Surgery, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
700    1_
$a Wöhner, Birte $u Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
700    1_
$a Zbodakova, Olga $u Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the ASCR, Prague, Czech Republic.
700    1_
$a Leuschner, Ivo $u Institute of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
700    1_
$a Martin, Gregor $u Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the ASCR, Prague, Czech Republic. Laboratory of Integrative Biology, Institute of Molecular Genetics of the ASCR, Prague, Czech Republic.
700    1_
$a Tiegs, Gisa $u Institute of Experimental Immunology and Hepatology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
700    1_
$a Rose-John, Stefan $u Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
700    1_
$a Sedlacek, Radislav $u Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the ASCR, Prague, Czech Republic.
700    1_
$a Tirnitz-Parker, Janina E E $u School of Biomedical Sciences, Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Bentley, Australia. School of Medicine and Pharmacology, University of Western Australia, Fremantle, Australia.
700    1_
$a Saftig, Paul $u Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
700    1_
$a Schmidt-Arras, Dirk $u Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany.
773    0_
$w MED00184852 $t Oncotarget $x 1949-2553 $g Roč. 7, č. 14 (2016), s. 17431-41
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26942887 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170427102316 $b ABA008
999    __
$a ok $b bmc $g 1200525 $s 974838
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 7 $c 14 $d 17431-41 $i 1949-2553 $m Oncotarget $n Oncotarget $x MED00184852
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Archiving options